Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06446570
Status:
COMPLETED
Last Update Posted:
2024-06-06
First Post:
2024-05-31
Brief Title:
Phase II Study of DurvalumabMEDI4736 Tremelimumab in Pulmonary Sarcomatoid Carcinoma
Sponsor:
Seoul National University Hospital
Organization:
Seoul National University Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-10
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-03
Completion Date Type:
ACTUAL
First Submit Date:
2024-05-31
First Submit QC Date:
May 31 2024
Study First Post Date:
2024-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-31
Last Update Post Date:
2024-06-06
Last Update Post Date Type:
ACTUAL